Literature DB >> 2209554

Specific structural alteration of the influenza haemagglutinin by amantadine.

R J Sugrue1, G Bahadur, M C Zambon, M Hall-Smith, A R Douglas, A J Hay.   

Abstract

Amantadine hydrochloride specifically blocks the release of virus particles from H7 influenza virus infected cells. This appears to be the direct consequence of an amantadine induced change in the haemagglutinin (HA) to its low pH conformation. The effect is indirect and mediated via interaction of the drug with the M2 protein since mutants altered in this component alone are insensitive to amantadine. The timing of drug action, some 15-20 min after synthesis, and its coincidence with proteolytic cleavage indicates that the modifications to HA occur late during transport but prior to insertion into the plasma membrane. Reversal by mM concentrations of amines and 0.1 microM monensin indicates that amantadine action causes a reduction in intravesicular pH which triggers the conformational change in HA. We conclude, therefore, that the function of M2 inhibited by amantadine is involved in counteracting the acidity of vesicular compartments of the exocytic pathway in infected cells and is important in protecting the structural integrity of the acid-sensitive glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209554      PMCID: PMC552095          DOI: 10.1002/j.1460-2075.1990.tb07555.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

2.  Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.

Authors:  J J Skehel; P M Bayley; E B Brown; S R Martin; M D Waterfield; J M White; I A Wilson; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

3.  Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.

Authors:  J E Warnick; M A Maleque; N Bakry; A T Eldefrawi; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1982-07       Impact factor: 4.436

4.  Visualization of acidic organelles in intact cells by electron microscopy.

Authors:  R G Anderson; J R Falck; J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

5.  Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine.

Authors:  A G Bukrinskaya; N K Vorkunova; N L Pushkarskaya
Journal:  J Gen Virol       Date:  1982-05       Impact factor: 3.891

6.  Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein.

Authors:  M D Lubeck; J L Schulman; P Palese
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

7.  Changes in the morphology of influenza particles induced at low pH.

Authors:  R W Ruigrok; A F Cremers; W E Beyer; F M de Ronde-Verloop
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion.

Authors:  R S Daniels; A R Douglas; J J Skehel; D C Wiley
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

9.  Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants.

Authors:  P N Graves; J L Schulman; J F Young; P Palese
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

10.  Acylation of viral spike glycoproteins: a feature of enveloped RNA viruses.

Authors:  M F Schmidt
Journal:  Virology       Date:  1982-01-15       Impact factor: 3.616

View more
  89 in total

1.  Definitive assignment of proton selectivity and attoampere unitary current to the M2 ion channel protein of influenza A virus.

Authors:  T I Lin; C Schroeder
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  The NB protein of influenza B virus is not necessary for virus replication in vitro.

Authors:  Masato Hatta; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 3.  Influenza M2 proton channels.

Authors:  Rafal M Pielak; James J Chou
Journal:  Biochim Biophys Acta       Date:  2010-05-06

4.  Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity.

Authors:  T Watanabe; S Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity.

Authors:  Jun Hu; Riqiang Fu; Katsuyuki Nishimura; Li Zhang; Huan-Xiang Zhou; David D Busath; Viksita Vijayvergiya; Timothy A Cross
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

6.  Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells.

Authors:  P G Hughey; R W Compans; S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  Assembly of the m2 tetramer is strongly modulated by lipid chain length.

Authors:  Sandra Schick; Lirong Chen; Edwin Li; Janice Lin; Ingo Köper; Kalina Hristova
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

8.  Proton and cation transport activity of the M2 proton channel from influenza A virus.

Authors:  Thom Leiding; Jun Wang; Jonas Martinsson; William F DeGrado; Sindra Peterson Arsköld
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

Review 9.  Ion channels as antivirus targets.

Authors:  Xin Liang; Zhi-Yuan Li
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

10.  Influenza B virus BM2 protein is transported through the trans-Golgi network as an integral membrane protein.

Authors:  Shinji Watanabe; Masaki Imai; Yoshiro Ohara; Takato Odagiri
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.